Those included: Nausea (about 29 to 42 percent of participants, depending on the dose) Diarrhea (25 to 34 percent) Constipation (24 to 26 percent) Vomiting (11 to 25 percent) Upper respiratory tract infection (12 to 14 percent) Interestingly, more people taking a placebo dropped out of the trial because of side effects than participants taking the lowest dose of retatrutide (4.9 percent compared with 4.1 percent)
Dizziness during dose escalation
Some manufacturers offer single-dose vials, and you draw the medication up yourself using the supplied needle and syringe
The dietary supplement industry is the Wild West, but people have kicked it up another notch by borrowing the name GLP-1, White tells TODAY.com
While wed love to guarantee that our patches work for everyone, its important to note that individual responses to any supplement or product, including our patches, can vary based on a persons unique physiology, lifestyle, and specific sleep-related issues, they said
Retatrutide remains investigational
